IRF1 and cancer: The critical function of IRF1 in the immune systems of various cancers has been explored (Kirchhoff et al., 1993; Kim et al., 2002), the clinical application and biological function of IRF1 in NSCLC patients who receiving chemoimmunotherapy remains unknown.